EP Patent

EP0279977A2 — Transdermal administration of progesterone, estradiol esters and mixtures thereof

Assigned to Alza Corp · Expires 1988-08-31 · 38y expired

What this patent protects

A transdermal delivery system for the administering of progesterone and an estradiol ester alone or in combination utilizing a polymer matrix having the drug(s) along with a permeation enhancer dispersed throughout.

USPTO Abstract

A transdermal delivery system for the administering of progesterone and an estradiol ester alone or in combination utilizing a polymer matrix having the drug(s) along with a permeation enhancer dispersed throughout.

Drugs covered by this patent

Patent Metadata

Patent number
EP0279977A2
Jurisdiction
EP
Classification
—
Expires
1988-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Alza Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.